Skip to content

Dr. Lieven WOSTYN

Active
Private limited companyfounded 1999active for 26 yearsAstridlaan(Odk) 1, 8670 Koksijde, BelgiumKBO/BCE: BE 0467.516.640
Summary

Dr. Lieven WOSTYN has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €2.7m and a net result of €541,479. Equity is growing by about 15% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Research and development on biotechnology
NACE 72101Specialist medical practice NACE 86220
#6 company by equity in West Flanders, Research and development sector1 site
Size
€3.1mtotal assets 2026
Staff
2 FTE
Equity
€2.7m
Profit
€541,479
Turnover not published (abbreviated format)
Financial health
96 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 50 days early0 of 6 deeds read
Why 96lowers riskLiquidity: current ratio 8.56, cash €508,767Figures for financial year 2026 (filed 11-09-2026)Equity €2.7m (88.6% of total assets)Size: 2 FTE, total assets €3.1mShow the evidence

Checked score

Score 2026
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 70% of its sector peers (NACE 72, micro)
Financial strength · tick = 2025
Strong
Solvency 100=
equity 88.6% of total assets
Liquidity 70+1
short-term debt 11.4% · cash 16.7%
Profitability 91-2
return on assets 17.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (936 companies, NACE 72, micro)
Last 24 months 11-2024: 0.1%highest value 12-2024: 0.1%● unchanged vs 11-2024highest value 01-2025: < 0.1%▼ -0.1 percentage points vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €250,000 on 30-day terms is acceptable
Liquidity ample (current ratio 8.56, compared with 9.61 in 2025; short-term debt: 11.4% and cash: 16.7% of total assets), and 11.4% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 83% on solvency, 58% on liquidity, 72% on profitability and 67% on growth.

The bankruptcy probability was computed on 09-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk○neutral
lowers risk · Liquidity: current ratio 8.56, cash €508,767
NBB · annual accounts
lowers risk · Figures for financial year 2026 (filed 11-09-2026)
NBB · annual accounts
lowers risk · Equity €2.7m (88.6% of total assets)
NBB · annual accounts
lowers risk · Size: 2 FTE, total assets €3.1m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 11-09-2026, 50 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
50 days early
2025
53 days early
2024
55 days early
2023
36 days early
2022
49 days early
2021
62 days early
2020
61 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 52 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 11 September (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
10-10-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · abbreviated…
  2. Highest result from 2019 to 2026net €541,479 ▲8.4%
  3. Annual accounts filedfinancial year 2025 · abbreviated…

Key points

  • Positive: Company by equity in West Flanders, Research and…in the Checked rankings #6 View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2026: €541,479 8 years View

By topic

Financials

Financial year
2026
Total assets
€3.1m
Profit
€541,479
Solvency
88.6%
Total assets▲ 17.0%
Net result
20192026
Go to Financials

Timeline

Events
29
Since
2002
Next accounts
by 31-10-2027
  1. 31-03-2025Equity above €2m
  2. 06-09-2024Annual accounts filed
  3. 25-09-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
22-11-1999
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.